It performs several functions: it signals the pancreas to release insulin, tells the liver to reduce glucose production, slows the speed at which food leaves your stomach (gastric emptying), and communicates with appetite-regulating centers in the brain
Genetic predispositions in appetite and energy expenditure pathways (FTO rs9939609, MC4R rs17782313, GIPR rs1800437) influence how aggressively semaglutide suppresses hunger and modulates satiety
Larger weight loss typically becomes apparent by week 6-8 as your body fully adjusts
This $99 add-on test reveals your unique peptide-pathway predispositions, helping your provider optimize compound selection and dosing strategy for superior outcomes specific to your biology
Semaglutide has been studied for weight management, type 2 diabetes, and cardiovascular risk reduction in certain patients